Yuichiro Hayashi Selected Research

Cisplatin (Platino)

10/2019	Proton Beam Therapy for Locally Recurrent Parotid Gland Cancer.
3/2019	Thermochemoradiotherapy Using Superselective Intra-arterial Infusion for Patients With Oral Cancer With Cervical Lymph Node Metastases.
1/2019	Retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab for carcinoma of the buccal mucosa with N3 lymph node metastasis: a case report.
7/2018	Daily Cisplatin and Weekly Docetaxel versus Weekly Cisplatin Intra-Arterial Chemoradiotherapy for Late T2-3 Tongue Cancer: A Pilot and Feasibility Trial.
3/2016	Treatment results of alternating chemoradiotherapy followed by proton beam therapy boost combined with intra-arterial infusion chemotherapy for stage III-IVB tongue cancer.
1/2016	Preliminary results of proton beam therapy combined with weekly cisplatin intra-arterial infusion via a superficial temporal artery for treatment of maxillary sinus carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuichiro Hayashi Research Topics

Disease

25	Neoplasms (Cancer) 05/2024 - 07/2011
14	Lung Neoplasms (Lung Cancer) 01/2021 - 04/2011
9	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2012
8	Adenocarcinoma of Lung 01/2023 - 04/2012
6	Carcinoma (Carcinomatosis) 02/2021 - 08/2008
5	Squamous Cell Carcinoma of Head and Neck 05/2023 - 01/2016
5	Stomach Neoplasms (Stomach Cancer) 01/2023 - 05/2016
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 11/2012
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 08/2013
4	Mouth Neoplasms (Oral Cancer) 09/2023 - 10/2017
4	Tongue Neoplasms (Tongue Neoplasm) 07/2018 - 03/2016
4	Adenocarcinoma 11/2017 - 08/2013
3	Lymphatic Metastasis 03/2019 - 04/2015
2	Inflammation (Inflammations) 01/2021 - 01/2016
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 09/2015
2	Hyperthermia 03/2019 - 01/2019
2	Carcinogenesis 01/2015 - 10/2014
2	Leukocytosis (Pleocytosis) 02/2012 - 02/2012
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 07/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2023
1	COVID-19 related adult multisystem inflammatory disease 05/2023
1	Wounds and Injuries (Trauma) 05/2023
1	Teratoma (Teratoid Tumor) 11/2022
1	Hypersensitivity (Allergy) 01/2022
1	Abdominal Aortic Aneurysm 01/2022
1	Ulcerative Colitis 02/2021
1	Colitis 02/2021
1	Diabetes Complications 01/2021
1	Multiple Myeloma 07/2020
1	Dehydration (Water Stress) 03/2020
1	Margins of Excision 03/2020
1	Thrombosis (Thrombus) 01/2020
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2020
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2020
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2020
1	Parotid Neoplasms 10/2019
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2019
1	Infections 01/2018
1	Gastroesophageal Reflux (GERD) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Cushing Syndrome 05/2016
1	Carcinoid Tumor (Carcinoid) 05/2016

Drug/Important Bio-Agent (IBA)

6	Cisplatin (Platino)FDA LinkGeneric 10/2019 - 01/2016
4	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2016
3	LigandsIBA 01/2023 - 11/2017
3	Docetaxel (Taxotere)FDA Link 03/2019 - 07/2018
3	ErbB Receptors (EGF Receptor)IBA 01/2017 - 11/2012
2	AlbuminsIBA 07/2023 - 01/2016
2	Cetuximab (Erbitux)FDA Link 05/2023 - 01/2019
2	InterferonsIBA 11/2022 - 02/2020
2	Immune Checkpoint InhibitorsIBA 02/2021 - 01/2021
2	NivolumabIBA 01/2021 - 01/2020
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2020 - 02/2012
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2012
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 10/2014
2	Biomarkers (Surrogate Marker)IBA 08/2013 - 11/2012
1	SuspensionsIBA 09/2023
1	CreatinineIBA 07/2023
1	Contrast MediaIBA 01/2022
1	AZD4547IBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	RamucirumabIBA 01/2021
1	sotorasibIBA 01/2021
1	pentaerythritolIBA 03/2020
1	AcidsIBA 03/2020
1	AntibodiesIBA 02/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2020
1	B7-H1 AntigenIBA 02/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	osimertinibIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Interferon-gamma (Interferon, gamma)IBA 11/2017
1	Granzymes (Granzyme)IBA 11/2017
1	ChemokinesIBA 11/2017
1	ceritinibIBA 01/2017
1	AfatinibIBA 01/2017
1	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2016

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 01/2021 - 01/2013
10	Intra-Arterial Infusions 05/2023 - 01/2016
9	Chemoradiotherapy 05/2023 - 03/2016
9	Therapeutics 01/2021 - 12/2012
8	Proton Therapy 10/2019 - 12/2015
8	Radiotherapy 01/2019 - 07/2011
5	Gastrectomy 01/2023 - 05/2016
2	Surgical Navigation Systems 03/2020 - 05/2016
2	Segmental Mastectomy (Lumpectomy) 01/2013 - 04/2012
1	Curettage 05/2024
1	Stents 07/2023
1	Surgical Instruments (Clip) 05/2023
1	Thoracoscopes 05/2023
1	Molecular Targeted Therapy 01/2021
1	General Anesthesia 01/2021
1	Glycemic Control 01/2021
1	Ligation 03/2019
1	Re-Irradiation 10/2017
1	Aftercare (After-Treatment) 10/2017
1	Prostheses and Implants (Prosthesis) 06/2016